Shaloam Dasari
Oncology · 2014
A researcher in the Science corpus: 1 paper; trusts 6 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Oncology — 14 citations into it; #1,473 of 1,698 by trust here, #1,501 by citations
- Molecular Biology — 11 citations into it; #15,998 of 17,773 by trust here, #15,203 by citations
- Genetics — 5 citations into it
Whom Shaloam Dasari trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Shaloam Dasari overall
Papers from Shaloam Dasari's perspective
Ordered by how strongly the researchers Shaloam Dasari trusts endorse each paper. Same corpus, a different order for every researcher.
- Ovarian cancer: strategies for overcoming resistance to chemotherapy (Nature Reviews. Cancer)
- Cellular processing of platinum anticancer drugs (Nature reviews. Drug discovery)
- Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases (Science)
- Cellular response to oxidative stress: Signaling for suicide and survival * (Journal of Cellular Physiology)
- Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. (Science)
- A family of drug transporters: the multidrug resistance-associated proteins. (Journal of the National Cancer Institute)
- Requirement for ERK Activation in Cisplatin-induced Apoptosis* (Journal of Biological Chemistry)
- Mammalian MAP kinase signalling cascades (Nature)
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (Nature)
- PUMA, a novel proapoptotic gene, is induced by p53. (Molecules and Cells)
Their papers
- Cisplatin in cancer therapy: molecular mechanisms of action (2014) — 5,019 citations